BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33886907)

  • 1. Acute radiodermatitis in cancer patients: incidence and severity estimates.
    Bontempo PSM; Ciol MA; Menêses AG; Simino GPR; Ferreira EB; Reis PEDD
    Rev Esc Enferm USP; 2021; 55():e03676. PubMed ID: 33886907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of acute radiodermatitis in women with breast cancer undergoing hypofractionated radiotherapy.
    Martelletti LBSJ; Aguiar BRL; Vieira LAC; Menêses AG; Bontempo PSM; Ferreira EB; Reis PEDD
    Rev Bras Enferm; 2021; 75(1):e20210118. PubMed ID: 34614087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of radiodermatitis in breast cancer patients during hypofractionated radiotherapy.
    Vieira LAC; Menêses AG; Bontempo PSM; Simino GPR; Ferreira EB; Guerra ENDS; Reis PEDD
    Rev Esc Enferm USP; 2022; 56():e20220173. PubMed ID: 36469486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis with a cream containing urea reduces the incidence and severity of radio-induced dermatitis.
    Pardo Masferrer J; Murcia Mejía M; Vidal Fernández M; Alvarado Astudillo A; Hernández Armenteros ML; Macías Hernández V; Soto Pérez R; Mirada Ferre A
    Clin Transl Oncol; 2010 Jan; 12(1):43-8. PubMed ID: 20080470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: a pilot study.
    Palatty PL; Azmidah A; Rao S; Jayachander D; Thilakchand KR; Rai MP; Haniadka R; Simon P; Ravi R; Jimmy R; D'souza PF; Fayad R; Baliga MS
    Br J Radiol; 2014 Jun; 87(1038):20130490. PubMed ID: 24694358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical use of Jiawei Simiao Yongan Gao to prevent radiodermatitis in patients with head and neck cancer: A retrospective cohort study.
    Song F; Liao Z; Li T; Kang N; Li Z; Fan S; Liu F
    Medicine (Baltimore); 2020 Nov; 99(48):e23318. PubMed ID: 33235092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of radiodermatitis and factors associated with its severity in women with breast cancer: a cohort study.
    Cavalcante LG; Domingues RAR; Junior BO; Fernandes MAR; Pessoa EC; Abbade LPF
    An Bras Dermatol; 2024; 99(1):57-65. PubMed ID: 37657957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors of acute radiodermatitis in breast cancer after adjuvant radiotherapy treated with RT3D or IMRT].
    Thomas A; Keller A; Menoux I; Brahimi Y; Vigneron C; Le Fèvre C; Chambrelant I; Pietta GA; Guihard S; Clavier JB; Antoni D; Noël G
    Cancer Radiother; 2022 Sep; 26(5):684-691. PubMed ID: 35227594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
    Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
    Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy induced dermatitis is a strong predictor for late fibrosis in head and neck cancer. The development of a predictive model for late fibrosis.
    Nevens D; Duprez F; Daisne JF; Laenen A; De Neve W; Nuyts S
    Radiother Oncol; 2017 Feb; 122(2):212-216. PubMed ID: 27663951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Team Health Education on Radiodermatitis in Patients with Head and Neck Tumor Radiotherapy Under the Joint Committee International Standards.
    Song Y; Zhang R; Yao T; Zhu X; Liu J; Deng L; Chen P
    Semin Oncol Nurs; 2021 Jun; 37(3):151148. PubMed ID: 34011460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ultrasonographic monitoring of skin condition in patients receiving radiotherapy for head and neck cancers.
    Pazdrowski J; Dańczak-Pazdrowska A; Polańska A; Kaźmierska J; Barczak W; Szewczyk M; Golusiński P; Adamski Z; Żaba R; Golusiński W
    Skin Res Technol; 2019 Nov; 25(6):857-861. PubMed ID: 31338911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypericum perforatum and neem oil for the management of acute skin toxicity in head and neck cancer patients undergoing radiation or chemo-radiation: a single-arm prospective observational study.
    Franco P; Potenza I; Moretto F; Segantin M; Grosso M; Lombardo A; Taricco D; Vallario P; Filippi AR; Rampino M; Ricardi U
    Radiat Oncol; 2014 Dec; 9():297. PubMed ID: 25544371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced skin cancer and radiodermatitis of the head and neck.
    van Vloten WA; Hermans J; van Daal WA
    Cancer; 1987 Feb; 59(3):411-4. PubMed ID: 3791154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute radiodermatitis in modern adjuvant 3D conformal radiotherapy for breast cancer - the impact of dose distribution and patient related factors.
    Borm KJ; Loos M; Oechsner M; Mayinger MC; Paepke D; Kiechle MB; Combs SE; Duma MN
    Radiat Oncol; 2018 Nov; 13(1):218. PubMed ID: 30404664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiodermatitis in patients irradiated for tumors of the face and neck].
    Cerovac V; Stanisavljević B; Djoković C; Krejović B; Vulić D
    Srp Arh Celok Lek; 1982 May; 110(5):607-10. PubMed ID: 7163907
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of acute skin toxicity with Hypericum perforatum and neem oil during platinum-based concurrent chemo-radiation in head and neck cancer patients.
    Franco P; Rampino M; Ostellino O; Schena M; Pecorari G; Garzino Demo P; Fasolis M; Arcadipane F; Martini S; Cavallin C; Airoldi M; Ricardi U
    Med Oncol; 2017 Feb; 34(2):30. PubMed ID: 28101834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.
    Tao Y; Auperin A; Sire C; Martin M; Saliou MG; Bardet E; Sun XS; Chatellier T; Morand C; Cornely A; Angokai M; Di Rito A; Kichenin K; Blanchard P; D'Onofrio I; Bourhis J
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):590-595. PubMed ID: 29280453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review.
    Bonomo P; Loi M; Desideri I; Olmetto E; Delli Paoli C; Terziani F; Greto D; Mangoni M; Scoccianti S; Simontacchi G; Francolini G; Meattini I; Caini S; Livi L
    Crit Rev Oncol Hematol; 2017 Dec; 120():98-110. PubMed ID: 29198343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of radiodermatitis associated with cetuximab in squamous cell carcinomas of the head and neck.
    Villavicencio M; Granados-García M; Vilajosana E; Domínguez-Cherit J
    Int J Dermatol; 2017 Jun; 56(6):602-609. PubMed ID: 28247918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.